John Overdeck’s Globus Medical GMED Stock Holding History

John Overdeck’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,000	Closed	-$383K	–	4497
2021 Q3	$383K	Buy	+5,000	New	+$401K	﹤0.01%	3468

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $3.12B AUM 53.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

John Overdeck's GMED Position: Q2 2025 in Review

John Overdeck sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 16,845 shares — an estimated $1.23M sold.

John Overdeck first reported a position in GMED in Q2 2013 and held it in 28 quarters. The position peaked at $71M in Q3 2023. 481 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

John Overdeck reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
John Overdeck sold 16,845 Globus Medical shares in Q2 2025, an estimated $1.23M.
John Overdeck first reported a position in Globus Medical in Q2 2013 and held it in 28 quarters.
John Overdeck's Globus Medical position peaked at $71M in Q3 2023.
481 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.